Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Engineered extracellular vesicles can improve tissue repair and regeneration.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Tissue-engineered scaffolds help heal difficult wounds by supporting cell growth and repair.

3D-bioprinting models of pancreatic cancer could help personalize treatments but need more testing.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

A reliable method was created to measure tamsulosin in human blood.

Exosome therapy may help treat diabetic nerve damage, but more research is needed.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Induced pluripotent stem cells are a major breakthrough in regenerative medicine.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Natural extracts may promote hair growth with fewer side effects than conventional treatments.

Bananas are highly nutritious and offer numerous health benefits, including anti-inflammatory and anticancer effects.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.

Menopause causes skin issues like dryness and wrinkles, which can be managed with lifestyle changes and treatments.

Regenerative therapies show promise for hair regrowth, but more research and standardization are needed.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Advanced techniques and technologies can improve burn wound healing, but more research is needed.

Exosomes could improve skin care, but more research is needed to confirm their safety and effectiveness.

Applying DMG-Na to the skin increases blood flow and may help with skin conditions.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.